Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-05-09 | Mineralys Therapeutics, Inc. | Rodman David Malcom
(Chief Medical Officer) |
S | Common Stock | D | 100 | $15.00 - $15.00 | $1,500 |
| 2024-05-09 | Mineralys Therapeutics, Inc. | Rodman David Malcom
(Chief Medical Officer) |
M | Common Stock | A | 100 | $1.08 - $1.08 | $108 |
| 2024-04-11 | Mineralys Therapeutics, Inc. | Rodman David Malcom
(Chief Medical Officer) |
M | Common Stock | A | 11366 | $0.54 - $1.08 | $9,565 |
| 2024-03-11 | Mineralys Therapeutics, Inc. | Rodman David Malcom
(Chief Medical Officer) |
M | Common Stock | A | 11365 | $0.54 - $1.08 | $9,564 |
| 2024-02-12 | Mineralys Therapeutics, Inc. | AKKARAJU SRINIVAS
(Director) |
A | Common Stock | A | 555555 | $13.50 - $13.50 | $7,499,992 |
| 2024-02-12 | Mineralys Therapeutics, Inc. | Samsara BioCapita...
(AtLeastTenPercentOwner) |
P | Common Stock | A | 555555 | $13.50 - $13.50 | $7,499,992 |
| 2024-02-12 | Mineralys Therapeutics, Inc. | Shah Rajeev M.
(Director) |
A | Common Stock | A | 1672508 | $13.50 - $13.50 | $22,578,858 |
| 2024-02-12 | Mineralys Therapeutics, Inc. | Rodman David Malcom
(Chief Medical Officer) |
M | Common Stock | A | 11366 | $0.54 - $1.08 | $9,565 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |